VenatoRx is a Pennsylvania-based pharmaceutical company that researches and develops antibacterial and antiviral drugs for the treatment of bacterial and viral infections... Read more
VenatoRx is a Pennsylvania-based pharmaceutical company that researches and develops antibacterial and antiviral drugs for the treatment of bacterial and viral infections... Read more
CEO
Add
News
Aug 16, 2025
Pharmabiz
Venatorx: Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibutenledaborbactam etzadroxil, a clinical phase 3ready oral BL/BLI combo to treat cUTI
May 16, 2024
Business Wire
Press Release: Venatorx : Venatorx Pharmaceuticals Announces Changes to Executive Leadership
May 13, 2024
The Business Journals: Philadelphia
Venatorx: Venatorx co-founder Christopher Burns steps down as CEO
Mar 12, 2024
Citybizlist
Venatorx: Venatorx Pharmaceuticals Expands Senior Leadership Team
Feb 26, 2024
Medthority
Venatorx: FDA issues Complete Response Letter for cefepime-taniborbactam application
Feb 23, 2024
Endpoints News
Venatorx: FDA rejects Melinta, Venatorx's UTI antibiotic over CMC issues
Feb 23, 2024
The Business Journals: Philadelphia
Venatorx: FDA rejects Venatorx Pharmaceuticals' new drug application for flagship product
Feb 21, 2024
The Business Journals: Philadelphia
Venatorx: Venatorx expects FDA ruling on its potential flagship product this week after years in development
Feb 20, 2024
BioSpace
Venatorx: New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection
Jan 10, 2024
Pharamceutical Technology
Venatorx: Venatorx and Menarini sign commercial deal for antibiotic
Venatorx Competitors
1
2
3
4
5
6
7
8
9
10